---
title: "Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactur... — FDA record D-0391-2026 | Is It on Recall"
description: "Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg"
url: https://isitonrecall.com/recall/fda-drug-d-0391-2026-pitavastatin-tablets-2-mg-packaged-in-90-count-bottles-rx-only-manufactured-for-northstar-rx-llc-mem/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38... — FDA record D-0391-2026

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Feb 3, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Annora Pharma Pvt. LTd., Sengareddy - 502313, Telengana, India, NDC 72603-479-01.
- **Reason**: Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg
- **Classification**: Class III
- **Recalling firm**: Annora Pharma Private Limited
- **Quantity**: 770 bottles
- **Agency-reported status**: Ongoing
- **Source record identifier**: D-0391-2026

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0391-2026%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot #: A252487, Exp 05/31/2027 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

TN

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Tennessee](https://isitonrecall.com/state/tennessee/)

## Dates in the source

- **Report date**: Mar 25, 2026
- **Recall initiation date**: Feb 3, 2026
- **Center classification date**: Mar 16, 2026

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0391-2026%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [Annora Pharma Private Limited records](https://isitonrecall.com/brand/annora-pharma-private-limited/)